Medicare is trying to curb an opaque industry practice that inflates what some older and disabled people pay for medicines under the federal insurance program’s prescription-drug plan. Medicare Part D, introduced in 2006 to extend drug coverage to beneficiaries, is provided through private health-insurance companies. Many insurers in turn contract with so-called pharmacy-benefit managers to […]
WASHINGTON (Reuters) – A $20 billion Medicare refinancing bill, paid for mostly by reducing Medicare’s reimbursement of private health plans, was blocked by U.S. lawmakers on Thursday, raising the likelihood a version with smaller cuts will emerge.
The legislators face a ticking clock